Indeed, the use of metformin has been shown to result in a long-term and more stable hypoglycemic effect than insulin/glyburide in women with resistant GDM, which may be associated with obesity-induced insulin resistance (28). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.